The use of novel beta blockers, such as carvedilol, for the prophylactic treatment of migraine is a new concept because it offers additional alpha-1 blocking and antioxidant properties.

Migraine affects nearly 12% of the adult population in occidental countries, imposing considerable economic and social losses. The pharmacologic treatment of migraine includes preventive and acute ...

Discover effective supplements for migraine prevention and learn who should or shouldn't use them. Explore evidence-based ...

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

31. Pike J, Mutebi A, Shah N, et al. Factors associated with a history of failure and switching migraine prophylaxis treatment: an analysis of clinical practice data from the USA, Germany ...

In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, ...

especially if the current treatment isn’t effective. A 2022 study found that only 24.9% of patients remained on their prescribed migraine prophylactic after 24 months. Among all patients ...

Some research studies give people with migraines up to 600 milligrams a day. Don’t take more than 1,200 milligrams a day. If you already take a multivitamin, check to see if it contains magnesium.

For patients with migraine, the clinical benefits of propranolol, a beta-blocker medication, may extend beyond just migraine ...

For patients with migraine, the clinical benefits of propranolol, a beta blocker medication, may extend beyond just migraine prophylaxis ... may lack access to new treatments, we must ensure ...